Cannaray is a leading European cannabis company spanning both medical THC and CBD wellness brands.
Cannaray has raised $13.1M in total funding. The most recent round was Series A. The last funding was announced in April 2022.
Cannaray's investors include Alpha Blue Ocean, Channel 4 Ventures, Three Bridges Private Capital, Malek Meslemani.
Cannaray is headquartered in London, United Kingdom.
Cannaray is a leading European cannabis company spanning both medical THC and CBD wellness brands.
Cannaray is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cannaray — Funding & Investors." VCBacked, April 4, 2022, https://www.vcbacked.co/company/cannaray. Accessed October 1, 2026.
VCBacked. (2022). Cannaray — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/cannaray
{{cite web |title=Cannaray — Funding & Investors |url=https://www.vcbacked.co/company/cannaray |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated